1. Home
  2. SNOA vs RUBI Comparison

SNOA vs RUBI Comparison

Compare SNOA & RUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNOA
  • RUBI
  • Stock Information
  • Founded
  • SNOA 1999
  • RUBI N/A
  • Country
  • SNOA United States
  • RUBI Marshall Islands
  • Employees
  • SNOA 168
  • RUBI N/A
  • Industry
  • SNOA Biotechnology: Pharmaceutical Preparations
  • RUBI Marine Transportation
  • Sector
  • SNOA Health Care
  • RUBI Consumer Discretionary
  • Exchange
  • SNOA Nasdaq
  • RUBI Nasdaq
  • Market Cap
  • SNOA 6.9M
  • RUBI 8.9M
  • IPO Year
  • SNOA 2007
  • RUBI N/A
  • Fundamental
  • Price
  • SNOA $4.32
  • RUBI $1.98
  • Analyst Decision
  • SNOA
  • RUBI
  • Analyst Count
  • SNOA 0
  • RUBI 0
  • Target Price
  • SNOA N/A
  • RUBI N/A
  • AVG Volume (30 Days)
  • SNOA 64.0K
  • RUBI 74.3K
  • Earning Date
  • SNOA 11-06-2025
  • RUBI 01-01-0001
  • Dividend Yield
  • SNOA N/A
  • RUBI N/A
  • EPS Growth
  • SNOA N/A
  • RUBI N/A
  • EPS
  • SNOA N/A
  • RUBI N/A
  • Revenue
  • SNOA $14,912,000.00
  • RUBI $24,139,000.00
  • Revenue This Year
  • SNOA $23.00
  • RUBI N/A
  • Revenue Next Year
  • SNOA $24.59
  • RUBI N/A
  • P/E Ratio
  • SNOA N/A
  • RUBI $1.00
  • Revenue Growth
  • SNOA 17.43
  • RUBI N/A
  • 52 Week Low
  • SNOA $1.75
  • RUBI $1.68
  • 52 Week High
  • SNOA $6.92
  • RUBI $6.69
  • Technical
  • Relative Strength Index (RSI)
  • SNOA 53.65
  • RUBI N/A
  • Support Level
  • SNOA $4.12
  • RUBI N/A
  • Resistance Level
  • SNOA $4.60
  • RUBI N/A
  • Average True Range (ATR)
  • SNOA 0.21
  • RUBI 0.00
  • MACD
  • SNOA 0.02
  • RUBI 0.00
  • Stochastic Oscillator
  • SNOA 67.05
  • RUBI 0.00

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

About RUBI Rubico Inc. Common Stock

Rubico Inc operates as a holding company. It is an eco-conscious international crude oil shipping company. The company's primary business is the ownership and operation of an eco-conscious fleet of tanker vessels designed for enhanced fuel efficiency, reduced greenhouse emissions, and a wide range of environmentally friendly technologies.

Share on Social Networks: